# Allison Jack & Chris Graf: Introducing TS 601 Biofungicide Page: https://stenobird.com/podcast/legend-in-the-field-7390713/allison-jack-chris-graf-introducing-ts-601-biofungicide Text version: https://stenobird.com/podcast/legend-in-the-field-7390713/allison-jack-chris-graf-introducing-ts-601-biofungicide.md Podcast: [Legend in the Field](https://stenobird.com/podcast/legend-in-the-field-7390713) Published: 2026-01-09T16:42:01+00:00 Episode link: https://rss.com/podcasts/legend-in-the-field/2414137 Audio file: https://content.rss.com/episodes/331701/2414137/legend-in-the-field/2026_01_09_14_41_53_00edaa04-cb72-4466-bf99-dcb5cbc41e5f.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/legend-in-the-field-7390713/episodes/allison-jack-chris-graf-introducing-ts-601-biofungicide Duration seconds: 1456 ## Resource We are kicking off Season Two of Legend in the Field with a deep dive into TS601, new EPA-registered soybean biofungicide offered by YieldMaster Solutions. Chris Graf with YMS and Allison Jack with NewLeaf Symbiotics join us as we discuss the "whats" and "hows" of this new product! Join the conversation in person: Visit YieldMaster Solutions at Commodity Classic, February 25–27 in San Antonio, TX , and don’t miss the panel discussion hosted by NewLeaf Symbiotics the evening of February 25 . ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/legend-in-the-field-7390713/episodes/allison-jack-chris-graf-introducing-ts-601-biofungicide/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/legend-in-the-field-7390713/allison-jack-chris-graf-introducing-ts-601-biofungicide.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.